GTX-11 attenuates lung fibrosis, inflammation and vascular remodeling in preclinical models of lung fibrotic disease

Key Points

• GTX-11 effectively attenuates lung fibrosis and inflammation, indicating a potential for treatment.
• In models, GTX-11 demonstrates antifibrotic activity both in vivo and in vitro, showcasing its versatility.
• The analysis involves preclinical models to evaluate the impact of GTX-11 on lung conditions.
• These findings suggest GTX-11 may serve as a promising therapeutic option for fibrotic lung diseases.

Abstract